Table 5.
5-year PFS of CR/PR/MR (95% CI) | 5-year PFS of SD/PD (95% CI) | HR (95% CI) | p value | C-index (95% CI) | |
---|---|---|---|---|---|
RECIST | 66.7% (33.7%–86.0%) | 66.7% (52.9%–77.3%) | 0.99 (0.34–2.92) | 0.99 | 0.50 (0.23–0.77) |
Modified RECIST | 66.7% (37.5%–84.6%) | 66.7% (52.4%–77.5%) | 1.00 (0.37–2.70) | 1.00 | 0.52 (0.28–0.77) |
WHO | 66.7% (37.5%–84.6%) | 66.7% (52.4%–77.5%) | 1.00 (0.37–2.70) | 1.00 | 0.52 (0.28–0.77) |
JOA | 60.0% (38.4%–76.1%) | 70.5% (54.6%–81.6%) | 1.41 (0.62–3.21) | 0.42 | 0.56 (0.36–0.77) |
Modified Choi | 59.3% (38.6%–75.0%) | 71.4% (55.2%–82.6%) | 1.54 (0.68–3.49) | 0.30 | 0.61 (0.42–0.81) |
CR complete response, PR partial response, MR minor response, SD stable disease, PD progressive disease, HR hazard ratio